Orbimed Advisors - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.7%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$826,781
-11.2%
802,7000.0%0.02%
+5.9%
Q2 2023$931,132
-23.2%
802,7000.0%0.02%
-29.2%
Q1 2023$1,212,077
-74.4%
802,700
-28.5%
0.02%
-72.7%
Q3 2022$4,739,000
-81.2%
1,123,000
-5.8%
0.09%
-60.2%
Q4 2020$25,225,000
+42.8%
1,191,8460.0%0.22%
-0.5%
Q3 2020$17,663,000
+81.8%
1,191,846
+80.5%
0.22%
+62.0%
Q2 2020$9,715,000
+54.0%
660,420
+22.9%
0.14%
+29.2%
Q1 2020$6,309,000
-75.9%
537,420
-49.7%
0.11%
-73.8%
Q1 2019$26,126,000
-28.1%
1,069,000
-23.7%
0.40%
-39.9%
Q4 2018$36,324,000
-24.2%
1,400,300
-7.5%
0.67%
+16.5%
Q3 2018$47,934,000
-6.2%
1,514,500
+15.2%
0.58%
-5.3%
Q2 2018$51,092,000
+62.4%
1,315,100
+15.4%
0.61%
+56.2%
Q1 2018$31,458,000
+167.4%
1,139,800
+75.4%
0.39%
+161.7%
Q4 2017$11,765,000
+12.1%
650,0000.0%0.15%
+49.0%
Q3 2017$10,498,000
+16.6%
650,0000.0%0.10%
+6.4%
Q2 2017$9,003,000
-7.7%
650,0000.0%0.09%
-15.3%
Q1 2017$9,750,000650,0000.11%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders